Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Vaszar, A. Piottante, E. Mark, U. Specks, S. Ytterberg, H. Tazelaar (Scottsdale, Rochester, Boston, United States Of America). Coexistent granulomatosis with polyangiitis (Wegener‘s) and Crohn disease: A clinicopathologic description of cases. Eur Respir J 2012; 40: Suppl. 56, 3121

Member's Comments

No comment yet.

Related content which might interest you: Granulomatosis with polyangiitis (Wegener&s) Source: Eur Respir Mon 2011; 54: 1-14 Year: 2011 Wegener granulomatosis : review of 16 cases Source: Eur Respir J 2002; 20: Suppl. 38, 314s Year: 2002 Secondary organizing pneumonia (BOOP)-associated with granulomatosis with polyangiitis [Wegener granulomatosis (WG)]: A clinicoradiological study of 19 cases Source: International Congress 2014 – ILDs 6 Year: 2014 New biomarkers for early diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA) Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Frequency of eosinophilic granulomatosis with polyangiitis in Europe by meta-analysis Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases Year: 2020 Pulmonary hypertension as the first manifestation in a patient with granulomatosis with polyangiitis Source: International Congress 2019 – Pulmonary vascular diseases? Year: 2019 Wegener's granulomatosis (WG) - clinical features and response to treatment in 18 cases Source: Eur Respir J 2002; 20: Suppl. 38, 64s Year: 2002 Physiological characteristics in patients with microscopic polyangitis (MPA) and wegener‘s granulomatosis (WG) Source: Eur Respir J 2004; 24: Suppl. 48, 327s Year: 2004 Clinical manifestation, approach to diagnosis and treatment of pulmonary vasculitis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=69 Year: 2005 Wegener's granulomatosis: our experience Source: Eur Respir J 2001; 18: Suppl. 33, 511s Year: 2001 Eosinophilic granulomatosis with polyangiitis Source: Eur Respir Monogr 2022; 95: 177-192 Year: 2022 Eosinophilic granulomatosis with polyangiitis Source: Eur Respir Monogr 2019; 86: 188-209 Year: 2019 Radiological findings in patients with Wegener granulomatosis Source: Eur Respir J 2003; 22: Suppl. 45, 593s Year: 2003 Lung-limited Granulomatosis with polyangiitis (GPA) managed without immunosuppression Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon Year: 2018 Microscopic polyangiitis and granulomatosis with polyangiitis Source: Eur Respir Monogr 2019; 86: 153-172 Year: 2019 Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss) Source: Eur Respir J 2016; 48: 1429-1441 Year: 2016 Eosinophilic granulomatosis with polyangiitis (formerly Churg–Strauss syndrome): where are we now? Source: Eur Respir J 2015; 46: 1255-1258 Year: 2015 Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis Source: ERJ Open Res, 6 (4) 00451-2020; 10.1183/23120541.00451-2020 Year: 2020 Biologics for eosinophilic granulomatosis with polyangiitis Source: Short video statement 2020 Year: 2020 Alveolar haemorrhage syndromes Source: Eur Respir Mon 2011; 54: 15-31 Year: 2011